Effects of treatment and drug resistance on the transmission dynamics of malaria in endemic areas.

We present a mathematical model for malaria treatment and spread of drug resistance in an endemic population. The model considers treated humans that remain infectious for some time and partially immune humans who are also infectious to mosquitoes although their infectiousness is always less than their non immune counterparts. The model is formulated by considering delays in the latent periods in both mosquito and human populations and in the period within which partial immunity is lost. Qualitative analysis of the model including positivity and boundedness of solutions is performed. Analysis of the reproductive numbers shows that if the treated humans become immediately uninfectious to mosquitoes then treatment will always reduce the number of sensitive infections. If however treated humans are infectious then for treatment to effectively reduce the number of sensitive infections, the ratio of the infectious period of the treated humans to the infectious period of the untreated humans multiplied by the ratio of the transmission rate from a treated human to the transmission rate of an untreated human should be less than one. Our results show that the spread of drug resistance with treatment as a control strategy depends on the ratio of the infectious periods of treated and untreated humans and on the transmission rates from infectious humans with resistant and sensitive infections. Numerical analysis is performed to assess the effects of treatment on the spread of resistance and infection. The study provides insight into the possible intervention strategies to be employed in malaria endemic populations with resistant parasites by identifying important parameters.

[1]  J. Kublin,et al.  Plasmodium falciparum crossresistance between trimethoprim and pyrimethamine , 2001, The Lancet.

[2]  J. W. Wekesa,et al.  Effect of Plasmodium falciparum on blood feeding behavior of naturally infected Anopheles mosquitoes in western Kenya. , 1992, The American journal of tropical medicine and hygiene.

[3]  J. Koella,et al.  The malaria parasite, Plasmodium falciparum, increases the frequency of multiple feeding of its mosquito vector, Anopheles gambiae , 1998, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[4]  S. H. Schmitz.  Effects of treatment or/and vaccination on HIV transmission in homosexuals with genetic heterogeneity , 2000 .

[5]  B. A. Harrison,et al.  Correlation of survival rates of Anopheles dirus A (Diptera: Culicidae) with different infection densities of Plasmodium cynomolgi. , 1986, Bulletin of the World Health Organization.

[6]  L. Bruce-Chwatt.  Chemotherapy of malaria. Revised 2nd editioncontinued. , 1986 .

[7]  V. do Rosário,et al.  Molecular characterisation of drug-resistant Plasmodium falciparum from Thailand , 2002, Malaria Journal.

[8]  Carlos Castillo-Chavez,et al.  Backwards bifurcations and catastrophe in simple models of fatal diseases , 1998, Journal of mathematical biology.

[9]  C. Drakeley,et al.  Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. , 2001, The Journal of infectious diseases.

[10]  J. Velasco-Hernández,et al.  A simple vaccination model with multiple endemic states. , 2000, Mathematical biosciences.

[11]  C. Kribs-Zaleta,et al.  Structured models for heterosexual disease transmission. , 1999, Mathematical biosciences.

[12]  M. Gatton,et al.  Evolution of Resistance to Sulfadoxine-Pyrimethamine in Plasmodium falciparum , 2004, Antimicrobial Agents and Chemotherapy.

[13]  A. Kaneko,et al.  Recovery of chloroquine sensitivity and low prevalence of the Plasmodium falciparum chloroquine resistance transporter gene mutation K76T following the discontinuance of chloroquine use in Malawi. , 2003, The American journal of tropical medicine and hygiene.

[14]  P. Olliaro,et al.  Averting a malaria disaster , 1999, The Lancet.

[15]  J. Kublin,et al.  Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. , 2003, The Journal of infectious diseases.

[16]  L. Molineaux,et al.  Changing patterns in the humoral immune response to malaria before, during, and after the application of control measures: a longitudinal study in the West African savanna. , 1978, Bulletin of the World Health Organization.

[17]  O. Sarr,et al.  Confirmation of emergence of mutations associated with atovaquone-proguanil resistance in unexposed Plasmodium falciparum isolates from Africa , 2006, Malaria Journal.

[18]  J. Koella,et al.  Epidemiological models for the spread of anti-malarial resistance , 2003, Malaria Journal.

[19]  O. Diekmann,et al.  On the definition and the computation of the basic reproduction ratio R0 in models for infectious diseases in heterogeneous populations , 1990, Journal of mathematical biology.

[20]  S. Aneke.  Mathematical modelling of drug resistant malaria parasites and vector populations , 2002 .

[21]  U. d’Alessandro,et al.  Modelling a predictable disaster: the rise and spread of drug-resistantmalaria. , 2000, Parasitology today.

[22]  J. Velasco-Hernández,et al.  A model for Chagas disease involving transmission by vectors and blood transfusion. , 1994, Theoretical population biology.

[23]  S. Lal,et al.  Epidemiology and control of malaria , 1999, Indian journal of pediatrics.

[24]  T. Harinasuta,et al.  EFFECT OF PRIMAQUINE ON GAMETOCYTES OF PLASMODIUM FALCIPARUM IN THAILAND , 1980, The Lancet.

[25]  K. Mendis,et al.  Features of recrudescent chloroquine-resistant Plasmodium falciparum infections confer a survival advantage on parasites and have implications for disease control. , 1996, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[26]  G. Pringle,et al.  Observations on the early course of untreated falciparum malaria in semi-immune African children following a short period of protection. , 1966, Bulletin of the World Health Organization.

[27]  A. Nzila,et al.  Towards an Understanding of the Mechanism of Pyrimethamine-Sulfadoxine Resistance in Plasmodium falciparum: Genotyping of Dihydrofolate Reductase and Dihydropteroate Synthase of Kenyan Parasites , 2000, Antimicrobial Agents and Chemotherapy.

[28]  A. Spielman,et al.  Increased biting rate and reduced fertility in sporozoite-infected mosquitoes. , 1986, The American journal of tropical medicine and hygiene.

[29]  C. Chiyaka,et al.  Transmission model of endemic human malaria in a partially immune population , 2007, Math. Comput. Model..

[30]  C. Plowe,et al.  Mechanisms of Resistance of Malaria Parasites to Antifolates , 2005, Pharmacological Reviews.

[31]  Ian M Hastings,et al.  Antimalarial drug resistance, artemisinin-based combination therapy, and the contribution of modeling to elucidating policy choices. , 2004, The American journal of tropical medicine and hygiene.

[32]  David L Smith,et al.  Statics and dynamics of malaria infection in Anopheles mosquitoes , 2004, Malaria Journal.

[33]  G. Macdonald.  The Epidemiology and Control of Malaria. , 1957 .

[34]  N. White,et al.  Antimalarial drug resistance and combination chemotherapy. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[35]  K. Barnes,et al.  Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum. , 2005, Acta tropica.

[36]  U. d’Alessandro,et al.  History and importance of antimalarial drug resistance , 2001, Tropical medicine & international health : TM & IH.

[37]  Michael Y. Li,et al.  Global stability for the SEIR model in epidemiology. , 1995, Mathematical biosciences.

[38]  S. Huijben,et al.  Competitive release and facilitation of drug-resistant parasites after therapeutic chemotherapy in a rodent malaria model , 2007, Proceedings of the National Academy of Sciences.

[39]  Qin Cheng,et al.  Modeling the Development of Acquired Clinical Immunity to Plasmodium falciparum Malaria , 2004, Infection and Immunity.

[40]  B. Knols,et al.  Plasmodium falciparum sporozoites increase feeding-associated mortality of their mosquito hosts Anopheles gambiae s.l. , 2000, Parasitology.

[41]  Leon Aarons,et al.  Mefloquine Pharmacokinetic-Pharmacodynamic Models: Implications for Dosing and Resistance , 2000, Antimicrobial Agents and Chemotherapy.

[42]  I. Hastings,et al.  A model for the origins and spread of drug-resistant malaria , 1997, Parasitology.

[43]  I. Hastings.  Gametocytocidal activity in antimalarial drugs speeds the spread of drug resistance , 2006, Tropical medicine & international health : TM & IH.

[44]  J. Koella,et al.  Relationship between body size of adult Anopheles gambiae s.l. and infection with the malaria parasite Plasmodium falciparum , 1992, Parasitology.

[45]  Nicolas Bacaer,et al.  A reaction-diffusion system modeling the spread of resistance to an antimalarial drug. , 2005, Mathematical biosciences and engineering : MBE.

[46]  Anders Björkman,et al.  Public health impact of drug resistant Plasmodium falciparum malaria. , 2005, Acta tropica.

[47]  David L Smith,et al.  Potential Impact of Intermittent Preventive Treatment (IPT) on Spread of Drug-Resistant Malaria , 2006, PLoS medicine.

[48]  I. Hastings.  The origins of antimalarial drug resistance. , 2004, Trends in parasitology.

[49]  A. Spielman,et al.  Increased intradermal probing time in sporozoite-infected mosquitoes. , 1984, The American journal of tropical medicine and hygiene.

[50]  J. Koella,et al.  The effect of Plasmodium yoelii nigeriensis infection on the feeding persistence of Anopheles stephensi Liston throughout the sporogonic cycle , 1999, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[51]  A. H. Song,et al.  Changes in the resistance of Plasmodium falciparum to chloroquine in Hainan, China. , 1995, Bulletin of the World Health Organization.

[52]  Joan L. Aron,et al.  Mathematical modelling of immunity to malaria , 1988 .

[53]  K. Day,et al.  Association of house spraying with suppressed levels of drug resistance in Zimbabwe , 2004, Malaria Journal.

[54]  N. White,et al.  The evolution of drug-resistant malaria: the role of drug elimination half-life. , 2002, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.